Biostax Corp (BTAX)

[locicat1]

Your postings are most interesting and, in general, pragmatic. Your comment "I just hope they realize that they should go for other markets too, simultaneously" is particularly pointed. If you have checked, or have time to do so, you should find in the past SEC filings that there were two meetings schduled and held at the FDA in mid-2013, approaching five years ago, regarding the use of (1) LDN as therapy for Crohn's Disease, both pediatric and adult and (2) methionine enkephalin as potential therapy for pancreatic cancer.

Nothing has moved forward in either of these areas since then. And apparently not because the FDA indicated any roadblocks. The simultaneous and necessary strategy ceased. Only the potential use of LDN in Africa was pursued.